Santen Pharmaceutical Co., Ltd.

$10.59

$0.02(-0.21%)

Santen Pharmaceutical Co., Ltd.

4536.T

$10.59

$0.02(-0.21%)

Santen Pharmaceutical Co., Ltd.

4536.T

JPX

$10.59

$0.02(-0.21%)

Chart

Upcoming Earnings

Next report date

May 12, 2026

Report period

Q2 2026

EPS Estimate

$0.21

Revenue Estimate

$486.17M

Key stats

52-Week Range$10.59

$8.20

$11.20

Market capitalization

$3.33B

Dividend yield (indicated)

2.27%

Price to earnings Ratio (TTM)

17.65

Basic EPS (TTM)

$0.57

Net income (TTM)

$197.06M

Revenue (TTM)

$1.84B

Avg. volume

917.16K

Beta (1Y)

0.33

Employees

3.74K

Market capitalization

$3.33B

Dividend yield (indicated)

2.27%

Price to earnings Ratio (TTM)

17.65

Basic EPS (TTM)

$0.57

Net income (TTM)

$197.06M

Revenue (TTM)

$1.84B

Avg. volume

917.16K

Beta (1Y)

0.33

Employees

3.74K

Screener Quick Check

About Santen Pharmaceutical Co., Ltd.

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Takeshi Ito

Website

www.santen.com

Headquarters

Grand Front Osaka Tower A, Osaka, 530-8552

IPO Date

2001-01-04

Identifiers

ISINJP3336000009

Description

Santen Pharmaceutical Co., Ltd. researches and develops, manufactures, and markets pharmaceuticals and medical devices in Japan...

Related Stocks

Sugi Holdings Co.,Ltd.

7649.T

$3,446.00Mkt Cap: $623.63B

Healthcare

Medical - Pharmaceuticals

ISIN:JP3397060009

COSMOS Pharmaceutical Corporation

3349.T

$50.12Mkt Cap: $3.97B

Healthcare

Medical - Pharmaceuticals

ISIN:JP3298400007

Dividend Overview

Dividend yield (indicated)

2.27%

Dividend per share

$0.24annual

Payout ratio (Earnings)

41.3%

Payout ratio (FCF)

34.5%

Dividend growth streak

Dividend CAGR (3Y)

-16.0%

Dividend CAGR (5Y)

-8.7%

Dividend CAGR (10Y)

-3.1%

Dividend yield (indicated)

2.27%

Dividend per share

$0.24annual

Payout ratio (Earnings)

41.3%

Payout ratio (FCF)

34.5%

Dividend growth streak

Dividend CAGR (3Y)

-16.0%

Dividend CAGR (5Y)

-8.7%

Dividend CAGR (10Y)

-3.1%

Financials

Performance

Margin trends

Debt level and coverage

Earnings

Next: Q2 '26

Actual

Estimate

Earnings

Next: Q2 '26

Actual

Estimate

Performance

Margin trends

Debt level and coverage

Earnings

Next: Q2 '26

Actual

Estimate

Earnings

Next: Q2 '26

Actual

Estimate